TD Asset Management
TNGX icon

TD Asset Management’s Tango Therapeutics TNGX Stock Holding History

TD Asset Management’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.94M Buy
221,968
+119,368
+116% +$2.95M 0.01% 737
2026
Q1 		$2.15M Buy
+102,600
New +$1.43M ﹤0.01% 950
2025
Q4 		– Sell
-18,072
Closed -$152K – 1297
2025
Q3 		$152K Buy
+18,072
New +$122K ﹤0.01% 1229
2024
Q4 		– Sell
-79,978
Closed -$597K – 1400
2024
Q3 		$597K Buy
79,978
+20,200
+34% +$193K ﹤0.01% 1276
2024
Q2 		$513K Hold
59,778
– – ﹤0.01% 1273
2024
Q1 		$475K Buy
+59,778
New +$641K ﹤0.01% 1308

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

TD Asset Management's TNGX Position: Q2 2026 in Review

TD Asset Management increased its Tango Therapeutics (TNGX) stake by 116% in Q2 2026, buying an estimated $2.95M and bringing the position to 221,968 shares worth $6.94M. The position accounts for 0.01% of the portfolio, ranked #737.

TD Asset Management first reported a position in TNGX in Q1 2024 and has held it in 6 quarters since. 248 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • TD Asset Management held 221,968 shares of Tango Therapeutics worth $6.94M as of Q2 2026.
  • TD Asset Management bought 119,368 Tango Therapeutics shares in Q2 2026, an estimated $2.95M.
  • Tango Therapeutics made up 0.01% of TD Asset Management's portfolio in Q2 2026, its #737 holding.
  • TD Asset Management first reported a position in Tango Therapeutics in Q1 2024 and has held it in 6 quarters since.
  • 248 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.